HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$0.70
Day range
$0.70 - $0.75
Year range
$0.44 - $3.54
Market cap
3.30M USD
Avg Volume
4.62K
P/E ratio
0.86
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 11.52M | 13.14% |
Operating expense | 5.54M | 6.62% |
Net income | 1.65M | 132.63% |
Net profit margin | 14.30 | 105.46% |
Earnings per share | — | — |
EBITDA | 1.92M | 65.01% |
Effective tax rate | 1.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.20M | -57.47% |
Total assets | 14.49M | 19.37% |
Total liabilities | 15.08M | -43.63% |
Total equity | -582.00K | — |
Shares outstanding | 4.42M | — |
Price to book | -5.38 | — |
Return on assets | 31.23% | — |
Return on capital | 125.34% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.65M | 132.63% |
Cash from operations | 1.24M | 2,229.31% |
Cash from investing | — | — |
Cash from financing | -1.50M | -150.00% |
Net change in cash | -265.00K | 61.37% |
Free cash flow | 741.38K | -88.10% |
About
Founded
1986
Headquarters
Website
Employees
111
